Co-assembled polypeptides-adsorbing bridge molecules to enhance macrophage efferocytosis for the resolution of periodontitis inflammation
Source abstract
Abstract
Effective removal of apoptotic cells, namely efferocytosis, promotes inflammation resolution of periodontitis and tissue restoration. However, effective treatments to enhance macrophage efferocytosis in periodontitis are still lacking. Co-assembly of distinct building blocks is considered a versatile and effective method of modulating the structure and functionality of supramolecular materials. Herein, a biologically inert amphiphile peptide (PA) (C 16 H 31 O NNCCCCS, PAS) was designed based on a previous amphiphile peptide (C 16 H 31 O NNCCCCRRES(p), PARRES). We described those two peptides' co-assembly in modulating macrophage efferocytosis for periodontitis resolution. The results showed that individual PAS and PARRES co-assemble together and transform the secondary structure from α-helix to β-sheet pattern via hydrogen bonding. Compared with individual PAs, the composite PA adsorbed more “bridging molecules” that enhance apoptotic signal binding on macrophages. The enriched “bridging molecules” could bind to macrophages on one side via phagocytic receptors and attract the apoptotic cells on the other side, thus promoting efferocytosis. When injected into mice with periodontitis, composite PA promotes inflammation resolution and further promotes periodontal tissue regeneration. This study provided an easily adjustable supermolecular system that enhances efferocytosis for periodontitis and revealed insights into the relationship between physicochemical properties and biological effects of supermolecular materials. Statement of significance Efferocytosis promotes periodontitis resolution and further tissue restoration. Nevertheless, high-performance therapeutics for promoting efferocytosis are still lacking. Peptides have desirable features, including biocompatibility and sequence-specific secondary structures. A biologically amphiphile peptide (PA) was designed with a similar structure to a previous PA. We described those PAs' co-assembly in modulating efferocytosis for periodontitis resolution. Specifically, those PAs co-assemble together and transform secondary structure from α-helix to β-sheet pattern. The composite PA adsorbs more “bridging molecules,” enhancing apoptotic signals binding to macrophages and attracting apoptotic cells for promoting efferocytosis. In vivo , the composite PA promotes periodontitis resolution and regeneration. This study provided an easily adjustable supermolecular system enhancing efferocytosis and revealed insights into the relationship between physicochemical properties and biological effects.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Phagocytosis and Immune Regulation · Immunotherapy and Immune Responses · Immune Response and Inflammation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (70)
Show source-provided references
1. Risk factors for periodontitis in children and young persons10.1034/j.1600-0757.2002.290110.x ↗
2. Neutrophils as protagonists and targets in chronic inflammation10.1038/nri.2017.10 ↗
3. Phagocytosis of apoptotic cells in resolution of inflammation10.3389/fimmu.2020.00553 ↗
4. DEL-1 promotes macrophage efferocytosis and clearance of inflammation10.1038/s41590-018-0249-1 ↗
5. Modulation of macrophage efferocytosis in inflammation10.3389/fimmu.2011.00057 ↗
6. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells10.1038/ni871 ↗
7. Self-assembling peptides as vectors for local drug delivery and tissue engineering applications10.1016/j.addr.2021.04.024 ↗
8. Synthetic cationic helical polypeptides for the stimulation of antitumour innate immune pathways in antigen-presenting cells10.1038/s41551-024-01194-7 ↗
9. Inter-crosslinking peptide augments 4-1BB receptor clustering for cancer immunotherapy10.1016/j.nantod.2023.102035 ↗
10. An in-situ peptide-antibody self-assembly to block CD47 and CD24 signaling enhances macrophage-mediated phagocytosis and anti-tumor immune responses10.1038/s41467-024-49825-6 ↗
11. Ultrasound-triggered biomimetic ultrashort peptide nanofiber hydrogels promote bone regeneration by modulating macrophage and the osteogenic immune microenvironment
12. 25th anniversary article: supramolecular materials for regenerative medicine10.1002/adma.201304606 ↗
13. Functional supramolecular polymers10.1126/science.1205962 ↗
14. Minimalistic peptide supramolecular co-assembly: expanding the conformational space for nanotechnology10.1039/C7CS00827A ↗
15. Bioactive scaffolds with enhanced supramolecular motion promote recovery from spinal cord injury10.1126/science.abh3602 ↗
16. Multicomponent self-assembly as a tool to harness new properties from peptides and proteins in material design10.1039/C8CS00121A ↗
17. Quantum mechanical assessment of protein-ligand hydrogen bond strength patterns: insights from semiempirical tight-binding and local vibrational mode theory10.3390/ijms24076311 ↗
18. Interaction of two peptide drugs with biomacromolecules analyzed by molecular docking and multi-spectroscopic methods10.1016/j.saa.2021.119673 ↗
19. A novel amphiphilic oligopeptide induced the intrafibrillar mineralisation via interacting with collagen and minerals10.1039/C9TB02928A ↗
20. Modulating the gelation properties of self-assembling peptide amphiphiles10.1021/nn900884n ↗
21. Effect of surface roughness of hydroxyapatite on human bone marrow cell adhesion, proliferation, differentiation and detachment strength10.1016/S0142-9612(00)00174-5 ↗
22. The dependence of osteoblastic response on variations in the chemical composition and physical properties of hydroxyapatite10.1023/A:1018558816871 ↗
23. Understanding interactions between biomaterials and biological systems using proteomics10.1016/j.biomaterials.2018.03.020 ↗
24. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it10.1080/02648725.1996.10647923 ↗
25. Biomaterials for bone regenerative engineering10.1002/adhm.201400760 ↗
26. Surface-induced changes in protein adsorption and implications for cellular phenotypic responses to surface interaction10.1016/j.biomaterials.2006.01.019 ↗
27. Diselenide-selenoester ligation for chemical protein synthesis10.1038/s41596-019-0180-4 ↗
28. CHARMM36m: an improved force field for folded and intrinsically disordered proteins10.1038/nmeth.4067 ↗
29. Universal sample preparation method for proteome analysis10.1038/nmeth.1322 ↗
30. Global quantification of mammalian gene expression control10.1038/nature10098 ↗
31. Quantitative proteomics reveals subset-specific viral recognition in dendritic cells10.1016/j.immuni.2010.01.013 ↗
32. clusterProfiler: an R package for comparing biological themes among gene clusters10.1089/omi.2011.0118 ↗
33. AlphaFold3 takes a step toward decoding molecular behavior and biological computation10.1038/s41594-024-01350-2 ↗
34. Position paper: periodontal maintenance10.1902/jop.2003.74.9.1395 ↗
35. Macrophage heterogeneity in tissues: phenotypic diversity and functions10.1111/imr.12223 ↗
36. Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer10.1038/cdd.2016.11 ↗
37. An antitumor peptide RS17-targeted CD47, design, synthesis, and antitumor activity10.1002/cam4.3768 ↗
38. Multicomponent dipeptide hydrogels as extracellular matrix-mimetic scaffolds for cell culture applications10.1039/C5CC03162A ↗
39. Control over multiple nano- and secondary structures in peptide self-assembly10.1002/anie.202113403 ↗
40. Tunable pentapeptide self-assembled β-sheet hydrogels10.1002/anie.201801001 ↗
41. Hierarchical assembly of tryptophan zipper peptides into stress-relaxing bioactive hydrogels10.1038/s41467-023-41907-1 ↗
42. New insight into protein secondary structure from resolution-enhanced infrared spectra10.1016/0167-4838(88)90107-0 ↗
43. An infrared spectroscopic study of the conformational transition of elastin-like polypeptides10.1529/biophysj.106.100594 ↗
44. Peptide-based nanomaterials: self-assembly, properties and applications
45. Thermodynamics of protein association reactions: forces contributing to stability10.1021/bi00514a017 ↗
46. Mediation of biomaterial-cell interactions by adsorbed proteins: a review10.1089/ten.2005.11.1 ↗
47. The molecular mechanism of mediation of adsorbed serum proteins to endothelial cells adhesion and growth on biomaterials10.1016/j.biomaterials.2013.04.028 ↗
48. Contribution of platelets, the coagulation and fibrinolytic systems to cutaneous wound healing10.1016/j.thromres.2019.05.001 ↗
49. Regulation of wound healing by growth factors and cytokines10.1152/physrev.2003.83.3.835 ↗
50. The anaphylatoxin C5a: structure, function, signaling, physiology, disease, and therapeutics10.1016/j.intimp.2023.110081 ↗
51. The complement system
52. The matricellular protein CCN1 mediates neutrophil efferocytosis in cutaneous wound healing10.1038/ncomms8386 ↗
53. C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway10.1046/j.1523-1755.2002.00139.x ↗
54. Profiling phagosome proteins identifies PD-L1 as a fungal-binding receptor10.1038/s41586-024-07499-6 ↗
55. NOX2 inhibition stabilizes vulnerable plaques by enhancing macrophage efferocytosis via MertK/PI3K/AKT pathway10.1016/j.redox.2023.102763 ↗
56. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis10.1038/343170a0 ↗
57. MafB is a critical regulator of complement component C1q10.1038/s41467-017-01711-0 ↗
58. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization10.1126/science.1104742 ↗
59. SIRT6-regulated macrophage efferocytosis epigenetically controls inflammation resolution of diabetic periodontitis10.7150/thno.78878 ↗
60. Neutrophils and NETs in modulating acute and chronic inflammation10.1182/blood-2018-11-844530 ↗
61. Efferocytosis in health and disease10.1038/s41577-019-0240-6 ↗
62. Activating macrophage continual efferocytosis via microenvironment biomimetic short fibers for reversing inflammation in bone repair10.1002/adma.202402968 ↗
63. Efferocytosis: an emerging therapeutic strategy for type 2 diabetes mellitus and diabetes complications10.2147/JIR.S418334 ↗
64. Antibody based affinity capture LC-MS/MS in quantitative determination of proteins in biological matrices10.1016/j.trac.2017.08.009 ↗
65. Analytical error and interference in immunoassay: minimizing risk10.1258/acb.2011.011073 ↗
66. Efferocytosis induces macrophage proliferation to help resolve tissue injury10.1016/j.cmet.2021.10.015 ↗
67. Inflammation and skeletal muscle regeneration: leave it to the macrophages!10.1016/j.it.2020.04.006 ↗
68. Peptide self-assembly: thermodynamics and kinetics10.1039/C6CS00176A ↗
69. Mediators of the resolution of the inflammatory response10.1016/j.it.2019.01.007 ↗
70. Cell removal: efferocytosis10.1146/annurev-cellbio-111315-125315 ↗